Eurofins Scientific SE
PAR:ERF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eurofins Scientific SE
Retained Earnings
Eurofins Scientific SE
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Eurofins Scientific SE
PAR:ERF
|
Retained Earnings
€4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
31%
|
|
Eurofins Scientific SE
Glance View
In the intricate realm of scientific services, Eurofins Scientific SE emerges as a quintessential powerhouse, orchestrating a symphony of analysis and testing across various industries. Founded in 1987, Eurofins began its journey with a focus on groundbreaking scientific methods for food and agriculture sectors. However, it rapidly diversified its expertise, leveraging its analytical prowess to expand into pharmaceuticals, environmental testing, and clinical diagnostics. The company operates through a network of laboratories scattered across the globe, each one serving as a beacon of quality and precision, embodying Eurofins' commitment to safeguarding consumer health, ensuring product safety, and supporting regulatory compliance. This robust infrastructure allows Eurofins to produce a constant stream of detailed and reliable test results, fueling its reputation and securing its place in the global market. Eurofins generates revenue primarily through its comprehensive suite of testing services, which cut across multiple sectors. Clients range from large corporations and government bodies to individual consumers who require specific tests. The company capitalizes on its broad spectrum of specialized tests, from determining the complex composition of food products to detecting elusive contaminants in pharmaceuticals and performing critical genetic screenings. This creates a diversified revenue stream that minimizes dependency on any single industry or service line. Eurofins' ability to continuously innovate and adapt its offerings ensures an ongoing inflow of clients seeking unparalleled testing accuracy and expertise. The combination of this vast service portfolio and relentless pursuit of scientific advancement underpins Eurofins' impressive financial performance and solidifies its pivotal role in the scientific services industry.
See Also
What is Eurofins Scientific SE's Retained Earnings?
Retained Earnings
4.1B
EUR
Based on the financial report for Dec 31, 2025, Eurofins Scientific SE's Retained Earnings amounts to 4.1B EUR.
What is Eurofins Scientific SE's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
31%
Over the last year, the Retained Earnings growth was -5%. The average annual Retained Earnings growth rates for Eurofins Scientific SE have been 1% over the past three years , 7% over the past five years , and 31% over the past ten years .